These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

669 related items for PubMed ID: 6208770

  • 1. European experience with the antiarrhythmic efficacy of propafenone for supraventricular and ventricular arrhythmias.
    Coumel P, Leclercq JF, Assayag P.
    Am J Cardiol; 1984 Nov 14; 54(9):60D-66D. PubMed ID: 6208770
    [Abstract] [Full Text] [Related]

  • 2. [Anti-arrhythmic effect of oral propafenone. Apropos of 70 cases].
    Coumel P, Leclercq JF, Assayag P, Maisonblanche P, Cauchemez B.
    Arch Mal Coeur Vaiss; 1984 Nov 14; 77(12):1370-82. PubMed ID: 6439161
    [Abstract] [Full Text] [Related]

  • 3. [The treatment of arrhythmias in infants and children using propafenone].
    Dressler F, Grävinghoff L, Grütte E, Jüngst BK, Liersch R, Nomayo H, Puls I, Rautenburg HW, Schmaltz A, Schumacher G.
    Monatsschr Kinderheilkd; 1985 Mar 14; 133(3):154-7. PubMed ID: 4010670
    [Abstract] [Full Text] [Related]

  • 4. Clinical experience with propafenone for cardiac arrhythmias in the young.
    Heusch A, Kramer HH, Krogmann ON, Rammos S, Bourgeous M.
    Eur Heart J; 1994 Aug 14; 15(8):1050-6. PubMed ID: 7527342
    [Abstract] [Full Text] [Related]

  • 5. [Amiodarone and propafenone: evaluation using serial Holter recordings in patients with ventricular arrhythmia].
    Ventosa A, Adragão P, Bonhorst D, Seabra-Gomes R.
    Rev Port Cardiol; 1990 Jan 14; 9(1):33-9. PubMed ID: 1691653
    [Abstract] [Full Text] [Related]

  • 6. [Oral propafenone in refractory arrhythmia. Apropos of 68 patients].
    Haissaguerre M, Wicker F, Goldrach S, Vrancea F, Regaudie JJ, Le Metayer P, Warin JF, Blanchot P.
    Ann Cardiol Angeiol (Paris); 1986 Mar 14; 35(3):173-9. PubMed ID: 3707020
    [Abstract] [Full Text] [Related]

  • 7. Effect of propafenone in the Wolff-Parkinson-White syndrome: electrophysiologic findings and long-term follow-up.
    Breithardt G, Borggrefe M, Wiebringhaus E, Seipel L.
    Am J Cardiol; 1984 Nov 14; 54(9):29D-39D. PubMed ID: 6496367
    [Abstract] [Full Text] [Related]

  • 8. Lidocaine, mexiletine and propafenone in the treatment of arrhythmias complicating myocardial infarction. A case report.
    Aguglia F, Gnecchi M, De Marzio P.
    Int J Cardiol; 1985 Mar 14; 7(3):303-6. PubMed ID: 2579918
    [Abstract] [Full Text] [Related]

  • 9. [Propafenon therapy of arrhythmias in infancy and childhood (author's transl)].
    Weber H, Eigster G, Wesselhoeft H.
    Monatsschr Kinderheilkd; 1981 Jul 14; 129(7):410-3. PubMed ID: 6167855
    [Abstract] [Full Text] [Related]

  • 10. Holter monitoring comparative assessment of propafenone and dihydroquinidine efficacy in the treatment of premature ventricular beats.
    Rizzon P, De Toma L, Mangini SG, Scrutinio D, Lagioia R, De Nicolò M.
    Cardiologia; 1983 Sep 14; 28(9):791-801. PubMed ID: 6398703
    [No Abstract] [Full Text] [Related]

  • 11. [What is safe in the therapy of tachycardic heart arrhythmias?].
    Wehr M, Noll B, Krappe J.
    Internist (Berl); 1985 Dec 14; 26(12):741-9. PubMed ID: 2417980
    [No Abstract] [Full Text] [Related]

  • 12. Propafenone therapy for ventricular tachycardia in the setting of congestive heart failure.
    Brodsky MA, Allen BJ, Abate D, Henry WL.
    Am Heart J; 1985 Oct 14; 110(4):794-9. PubMed ID: 4050651
    [Abstract] [Full Text] [Related]

  • 13. Guidelines for the use of propafenone in treating supraventricular arrhythmias.
    Kishore AG, Camm AJ.
    Drugs; 1995 Aug 14; 50(2):250-62. PubMed ID: 8521758
    [Abstract] [Full Text] [Related]

  • 14. Oral propafenone in the suppression of chronic stable ventricular arrhythmias.
    Schamroth L, Myburgh DP, Schamroth CL, Scholtz ME, Pincus DR, Kawalsky DL.
    Chest; 1985 Apr 14; 87(4):448-51. PubMed ID: 3884286
    [Abstract] [Full Text] [Related]

  • 15. Treatment of cardiac arrhythmias.
    Robinson SJ.
    Pediatr Clin North Am; 1964 May 14; 11(2):315-62. PubMed ID: 4174540
    [No Abstract] [Full Text] [Related]

  • 16. Problems of antiarrhythmic treatment in children.
    Coumel P, Fidelle J.
    Cardiologia; 1983 Sep 14; 28(9):767-82. PubMed ID: 6687332
    [No Abstract] [Full Text] [Related]

  • 17. Electrophysiological assessment of amiodarone in treatment of resistant supraventricular arrhythmias.
    Rowland E, Krikler DM.
    Br Heart J; 1980 Jul 14; 44(1):82-90. PubMed ID: 7426165
    [Abstract] [Full Text] [Related]

  • 18. [Effects of anti-arrhythmia agents on heart rate. Significance and importance].
    Leclercq JF, Georgiopoulos G, Halkidis H, Attuel P, Maisonblanche P, Coumel P.
    Arch Mal Coeur Vaiss; 1981 Dec 14; 74 Spec No():37-46. PubMed ID: 6122434
    [No Abstract] [Full Text] [Related]

  • 19. Pharmacologic management of supraventricular tachycardias in children. Part 2: Atrial flutter, atrial fibrillation, and junctional and atrial ectopic tachycardia.
    Luedtke SA, Kuhn RJ, McCaffrey FM.
    Ann Pharmacother; 1997 Nov 14; 31(11):1347-59. PubMed ID: 9391691
    [Abstract] [Full Text] [Related]

  • 20. Safety of oral propafenone in the treatment of arrhythmias in infants and children (European retrospective multicenter study). Working Group on Pediatric Arrhythmias and Electrophysiology of the Association of European Pediatric Cardiologists.
    Janousek J, Paul T.
    Am J Cardiol; 1998 May 01; 81(9):1121-4. PubMed ID: 9605053
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.